For the past three-and-a-half years he has been a partner at Truffert and Company, a debt capital markets headhunting firm set up by Philippe Truffert, Gindre's boss at UBS in the early 1990s.
Before joining Truffert he held a variety of positions as head of debt origination, including spells at Commerzbank, UBS, BZW, and Chase Manhattan.
But he's not going back to the same kind of role. Instead he is to be the head of the London office of IXIS Corporate and Investment Bank, the new name of CDC IXIS.
Gindre decided to go back to banking after completing his MBA at the London Business School. With the market slowdown after September 11 I decided I ought to do something to occupy my time in addition to working at Truffert, and had always wanted to do an MBA, says Gindre, who studied part-time over two years.
He takes over from Guido Rauch, who was global head of equity derivatives in addition to running the London office. He resigned in mid-November.
The bank has been going through changes following the acquisition in July by Groupe Caisse d'Epargne of a controlling stake in CDC IXIS, creating France's third-largest bank.
Gindre has responsibility for all the business in London, in both investment and commercial banking, Never having played the league-table game, IXIS isn't the first name to come to mind when thinking about investment banking. That appealed to Gindre. If they'd asked me to come back and try to beat, say, SG, in debt underwriting within two years, I would not have been interested.
What it does have, though, are decent, if small, and profitable operations in debt and equity underwriting, securitization, equity and interest-rate derivatives, real estate and in dealing with hedge funds. And Gindre's brief is to expand on that. This bank's a big sleeping giant outside of France, says Gindre. But we're waking up, and intend to expand significantly the UK operations.